BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang HY, Chen J, Xia CC, Cao LK, Duan T, Song B. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World J Gastroenterol 2018; 24(22): 2348-2362 [PMID: 29904242 DOI: 10.3748/wjg.v24.i22.2348] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 37] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Wang Y, Xu J, Song Q, Shangguan J, Xue M, Wang H, Gan J, Gao W. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. Sci Prog 2021;104:368504211029429. [PMID: 34315286 DOI: 10.1177/00368504211029429] [Reference Citation Analysis]
2 Kong Y, Jing Y, Sun H, Zhou S, M.a B. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer. Journal of Healthcare Engineering 2022;2022:1-10. [DOI: 10.1155/2022/5074571] [Reference Citation Analysis]
3 Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695 [PMID: 31528094 DOI: 10.3748/wjg.v25.i32.4682] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
4 Oksuzoglu K, Ones T, Ozguven S, Inanir S, Turoglu HT, Bozkurtlar E, Celikel CA, Erdil TY. Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinoma. Medicine (Baltimore) 2018;97:e12817. [PMID: 30334977 DOI: 10.1097/MD.0000000000012817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Çelebi F, Görmez A, Serkan Ilgun A, Tokat Y, Cem Balcı N. The role of 18F- FDG PET/MRI in preoperative prediction of MVI in patients with HCC. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK. An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice. J Hepatocell Carcinoma 2021;8:645-56. [PMID: 34235103 DOI: 10.2147/JHC.S312921] [Reference Citation Analysis]
7 Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF. Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model. J Hepatocell Carcinoma 2021;8:71-83. [PMID: 33728278 DOI: 10.2147/JHC.S287800] [Reference Citation Analysis]
8 Wei Y, Huang Z, Tang H, Deng L, Yuan Y, Li J, Wu D, Wei X, Song B. IVIM improves preoperative assessment of microvascular invasion in HCC. EurRadiol. 2019;29:5403-5414. [PMID: 30877465 DOI: 10.1007/s00330-019-06088-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
9 Saito N, Tanaka T, Minamiguchi K, Taiji R, Nishiofuku H, Matsumoto T, Hirai T, Kichikawa K, Kawahara N, Matsuda D, Akiyama I. Ultrasonic Heating Detects Lipiodol Deposition within Liver Tumors after Transarterial Embolization: An In Vivo Approach. Biology (Basel) 2021;10:901. [PMID: 34571777 DOI: 10.3390/biology10090901] [Reference Citation Analysis]
10 Korn RL, Rahmanuddin S, Borazanci E. Use of Precision Imaging in the Evaluation of Pancreas Cancer. Cancer Treat Res 2019;178:209-36. [PMID: 31209847 DOI: 10.1007/978-3-030-16391-4_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Zhang T, Wei Y, He X, Yuan Y, Yuan F, Ye Z, Li X, Tang H, Song B. Prediction of Remnant Liver Regeneration after Right Hepatectomy in Patients with Hepatocellular Carcinoma Using Preoperative CT Texture Analysis and Clinical Features. Contrast Media Mol Imaging 2021;2021:5572470. [PMID: 34220379 DOI: 10.1155/2021/5572470] [Reference Citation Analysis]
12 Zhang Y, Wang C, Xu H, Xiao P, Gao Y. Hepatocellular carcinoma in the noncirrhotic liver: a literature review. Eur J Gastroenterol Hepatol 2019;31:743-8. [PMID: 31008808 DOI: 10.1097/MEG.0000000000001419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zhu M, Li H, Wang C, Yang B, Wang X, Hou F, Yang S, Wang Y, Guo X, Qi X. Focal nodular hyperplasia mimicking hepatocellular adenoma and carcinoma in two cases. Drug Discov Ther 2021;15:112-7. [PMID: 33952777 DOI: 10.5582/ddt.2021.01033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tan J, Sun X, Wang S, Ma B, Chen Z, Shi Y, Zhang L, Shah MA. Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare. J Healthc Eng 2021;2021:8666498. [PMID: 34671450 DOI: 10.1155/2021/8666498] [Reference Citation Analysis]
15 Yu L, Xu H, Zhang S, Chen J, Yu Z. SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway. Hum Cell 2020;33:721-9. [PMID: 32314115 DOI: 10.1007/s13577-020-00362-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Florea M, Serban T, Tirpe GR, Tirpe A, Lupsor-Platon M. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography. J Clin Med 2021;10:2575. [PMID: 34200885 DOI: 10.3390/jcm10122575] [Reference Citation Analysis]
17 Zhu J, Tang B, Lv X, Meng M, Weng Q, Zhang N, Li J, Fan K, Zheng L, Fang S, Xu M, Ji J. Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Front Oncol 2020;10:519180. [PMID: 33680905 DOI: 10.3389/fonc.2020.519180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Wang SH, Han XJ, Du J, Wang ZC, Yuan C, Chen Y, Zhu Y, Dou X, Xu XW, Xu H, Yang ZH. Saliency-based 3D convolutional neural network for categorising common focal liver lesions on multisequence MRI. Insights Imaging 2021;12:173. [PMID: 34817732 DOI: 10.1186/s13244-021-01117-z] [Reference Citation Analysis]
19 Chang Q, Xu Y, Wang J, Jing H, Rao L, Tang W, Zhang Z, Wu X. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Comput Math Methods Med 2021;2021:8556888. [PMID: 34819993 DOI: 10.1155/2021/8556888] [Reference Citation Analysis]
20 Chen W, Huang L, Liang J, Ye Y, Yu S, Zhang Y. Long noncoding RNA small nucleolar RNA host gene 15 deteriorates liver cancer via microRNA-18b-5p/LIM-only 4 axis. IUBMB Life 2021;73:349-61. [PMID: 33372376 DOI: 10.1002/iub.2431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Katrich A, Petrovskiy A, Katrich N, Porkhanov V. Ultrasound in a differentiated treatment approach for liver diseases. Khir Z im N I Pirogova 2021. [DOI: 10.17116/hirurgia202112134] [Reference Citation Analysis]
22 Filippi L, Schillaci O. New kid on the block in theranostics: Glypican-3. Clin Transl Imaging 2021;9:199-201. [DOI: 10.1007/s40336-021-00413-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wei J, Jiang H, Gu D, Niu M, Fu F, Han Y, Song B, Tian J. Radiomics in liver diseases: Current progress and future opportunities. Liver Int 2020;40:2050-63. [PMID: 32515148 DOI: 10.1111/liv.14555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Castello A, Lopci E. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utility. Clin Transl Imaging 2020;8:377-92. [DOI: 10.1007/s40336-020-00384-y] [Reference Citation Analysis]
25 Kawaguchi T, Shimose S, Torimura T. Challenges and prospects in prediction and treatment for hepatocellular carcinoma with microvascular invasion. Hepatobiliary Surg Nutr 2019;8:651-4. [PMID: 31929999 DOI: 10.21037/hbsn.2019.08.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Wei Y, Deng L, Yuan Y, Huang Z, He X, Wei X, Yang H, Song B. Gadoxetate acid disodium-enhanced MRI: Multiple arterial phases using differential sub-sampling with cartesian ordering (DISCO) may achieve more optimal late arterial phases than the single arterial phase imaging. Magn Reson Imaging 2019;61:116-23. [PMID: 31129279 DOI: 10.1016/j.mri.2019.05.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Burti S, Zotti A, Bonsembiante F, Contiero B, Banzato T. Diagnostic Accuracy of Delayed Phase Post Contrast Computed Tomographic Images in the Diagnosis of Focal Liver Lesions in Dogs: 69 Cases. Front Vet Sci 2021;8:611556. [PMID: 33748206 DOI: 10.3389/fvets.2021.611556] [Reference Citation Analysis]
28 Oriakhi M, Andrabi SA, Olutoyin A, Ahluwalia M. A Rare Presentation of Hepatocellular Carcinoma Infiltrating the Gallbladder. Cureus 2019;11:e5140. [PMID: 31523569 DOI: 10.7759/cureus.5140] [Reference Citation Analysis]
29 Wang F, Numata K, Nakano M, Tanabe M, Chuma M, Nihonmatsu H, Nozaki A, Ogushi K, Luo W, Ruan L, Okada M, Otani M, Inayama Y, Maeda S. Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma. Diagnostics (Basel) 2020;10:E321. [PMID: 32438701 DOI: 10.3390/diagnostics10050321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
30 Marschner CA, Zhang L, Schwarze V, Völckers W, Froelich MF, von Münchhausen N, Schnitzer ML, Geyer T, Fabritius MP, Rübenthaler J, Clevert DA. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1. Clin Hemorheol Microcirc 2020;76:453-8. [PMID: 33216017 DOI: 10.3233/CH-209221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kovac JD, Milovanovic T, Dugalic V, Dumic I. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol 2020; 26(17): 2012-2029 [PMID: 32536771 DOI: 10.3748/wjg.v26.i17.2012] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Ghadimi M, Birnbaum J, Kamel IR, Sirlin CB, Chernyak V. What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria? Eur Radiol 2021. [PMID: 34807269 DOI: 10.1007/s00330-021-08389-5] [Reference Citation Analysis]
33 Wang F, Numata K, Nihonmatsu H, Okada M, Maeda S. Application of new ultrasound techniques for focal liver lesions. J Med Ultrason (2001) 2020;47:215-37. [PMID: 31950396 DOI: 10.1007/s10396-019-01001-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol 2021:S0168-8278(21)02099-7. [PMID: 34624411 DOI: 10.1016/j.jhep.2021.09.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
35 Xu G, Yang H, Xu H. Prediction of microvascular invasion in hepatocellular carcinoma with preoperative imaging radiomic analysis: Is it ready for prime time? Hepatobiliary & Pancreatic Diseases International 2019;18:289-90. [DOI: 10.1016/j.hbpd.2019.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Mohamed AA, Omran D, El-Feky S, Darwish H, Kassas A, Farouk A, Ezzat O, Abdo SM, Zahran FE, El-Demery A, Omran MM. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. Br J Biomed Sci 2021;78:18-22. [PMID: 32573389 DOI: 10.1080/09674845.2020.1778842] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Tramontano L, Cavaliere C, Salvatore M, Brancato V. The Role of Non-Gaussian Models of Diffusion Weighted MRI in Hepatocellular Carcinoma: A Systematic Review. J Clin Med 2021;10:2641. [PMID: 34203995 DOI: 10.3390/jcm10122641] [Reference Citation Analysis]
38 Nan Y, Xu X, Gao Y, Wang R, Li W, Yang M, Liu L, Duan Z, Jia J, Wei L, Zhuang H; Chinese Society of Hepatology, Chinese Medical Association. Consensus on the secondary prevention of primary liver cancer. Hepatol Int 2021;15:1289-300. [PMID: 34846705 DOI: 10.1007/s12072-021-10259-7] [Reference Citation Analysis]
39 Karmacharya MB, Sultan LR, Kirkham BM, Brice AK, Wood AKW, Sehgal CM. Photoacoustic Imaging for Assessing Tissue Oxygenation Changes in Rat Hepatic Fibrosis. Diagnostics (Basel) 2020;10:E705. [PMID: 32957666 DOI: 10.3390/diagnostics10090705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Clarke CGD, Albazaz R, Smith CR, Rowe I, Treanor D, Wyatt JI, Sheridan MB, Guthrie JA. Comparison of LI-RADS with other non-invasive liver MRI criteria and radiological opinion for diagnosing hepatocellular carcinoma in cirrhotic livers using gadoxetic acid with histopathological explant correlation. Clin Radiol 2021;76:333-41. [PMID: 33461746 DOI: 10.1016/j.crad.2020.12.007] [Reference Citation Analysis]
41 Cai Z, Zhang J, He Y, Xia L, Dong X, Chen G, Zhou Y, Hu X, Zhong S, Wang Y, Chen H, Xie D, Liu X, Liu J. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma. ESMO Open 2021;6:100021. [PMID: 33508734 DOI: 10.1016/j.esmoop.2020.100021] [Reference Citation Analysis]
42 Miao W, Nie P, Yang G, Wang Y, Yan L, Zhao Y, Yu T, Yu M, Wu F, Rao W, Wang Z. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation. Eur J Nucl Med Mol Imaging 2021. [PMID: 33813592 DOI: 10.1007/s00259-021-05328-w] [Reference Citation Analysis]
43 Mansour R, Thibodeau Antonacci A, Bilodeau L, Vazquez Romaguera L, Cerny M, Huet C, Gilbert G, Tang A, Kadoury S. Impact of temporal resolution and motion correction for dynamic contrast-enhanced MRI of the liver using an accelerated golden-angle radial sequence. Phys Med Biol 2020;65:085004. [PMID: 32084661 DOI: 10.1088/1361-6560/ab78be] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kaissis GA, Lohöfer FK, Hörl M, Heid I, Steiger K, Munoz-Alvarez KA, Schwaiger M, Rummeny EJ, Weichert W, Paprottka P, Braren R. Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma. Eur J Radiol 2020;124:108848. [PMID: 32006931 DOI: 10.1016/j.ejrad.2020.108848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Wang SH, Yeh SH, Chen PJ. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers (Basel) 2021;13:2454. [PMID: 34070067 DOI: 10.3390/cancers13102454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R, Izzo F, Petrillo A. The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer. 2018;13:23. [PMID: 29988667 DOI: 10.1186/s13027-018-0194-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
47 Ayoub WS, Steggerda J, Yang JD, Kuo A, Sundaram V, Lu SC. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers. Ther Adv Med Oncol. 2019;11:1758835919869120. [PMID: 31523283 DOI: 10.1177/1758835919869120] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
48 Ghouraba MH, Masad RJ, Mpingirika EZ, Abdelraheem OM, Zeghlache R, Alserw AM, Amleh A. Role of NELF-B in supporting epithelial-mesenchymal transition and cell proliferation during hepatocellular carcinoma progression. Oncol Lett 2021;22:761. [PMID: 34539865 DOI: 10.3892/ol.2021.13022] [Reference Citation Analysis]
49 Kitamura S, Kai K, Nakamura M, Tanaka T, Ide T, Noshiro H, Sueoka E, Aishima S. Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens. Cancers 2022;14:2301. [DOI: 10.3390/cancers14092301] [Reference Citation Analysis]
50 Jiang T, He S, Yang H, Dong Y, Yu T, Luo Y, Jiang X. Multiparametric MRI-based radiomics for the prediction of microvascular invasion in hepatocellular carcinoma. Acta Radiol 2022;:2841851221080830. [PMID: 35354318 DOI: 10.1177/02841851221080830] [Reference Citation Analysis]
51 He Z, Huang Q, Liao Y, Xu X, Wu Q, Nong Y, Peng N, He W, Pallikonda Rajasekaran M. Artificial Intelligence Algorithm in Classification and Recognition of Primary Hepatic Carcinoma Images under Magnetic Resonance Imaging. Contrast Media & Molecular Imaging 2022;2022:1-11. [DOI: 10.1155/2022/8950600] [Reference Citation Analysis]
52 Krumeich LN, Mancinelli J, Cucchiara A, Eddinger K, Aufhauser D Jr, Goldberg DW, Siegelman ES, Rosen M, Reddy KR, Hoteit M, Furth EE, Olthoff KM, Shaked A, Levine M, Abt P. Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients. Liver Transpl 2021;27:1248-61. [PMID: 33853207 DOI: 10.1002/lt.26073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Lupsor-Platon M, Serban T, Silion AI, Tirpe GR, Tirpe A, Florea M. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers (Basel) 2021;13:790. [PMID: 33672827 DOI: 10.3390/cancers13040790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]